Animal Models of Hepatocellular Carcinoma for Local-Regional Intraarterial Therapies

被引：4
|
作者：
Chandra, Vishnu M. [1 ]
Wilkins, Luke R. [1 ]
Brautigan, David L. [2 ]
机构：
[1] Univ Virginia Hlth Syst, Dept Radiol & Med Imaging, 1215 Lee St,POB 800170, Charlottesville, VA 22908 USA
[2] Univ Virginia Hlth Syst, Dept Microbiol Immunol & Canc Biol, 1215 Lee St,POB 800170, Charlottesville, VA 22908 USA
来源：
RADIOLOGY-IMAGING CANCER | 2022年 / 4卷 / 04期
关键词：
Animal Studies; Interventional-Vascular; Molecular Imaging-Clinical; Translation; Molecular Imaging-Cancer; Chemoembolization; Liver; VX2; TUMOR-MODEL; RAT MODEL; TRANSARTERIAL EMBOLIZATION; RADIOFREQUENCY ABLATION; LIVER-CANCER; CHEMOEMBOLIZATION; WOODCHUCK; HEPATOMA; EXPRESSION; MICRORNAS;
D O I：
10.1148/rycan.210098
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Animal models play a crucial role in developing and testing new therapies for hepatocellular carcinoma (HCC), providing preclinical evidence prior to exploring human safety and efficacy outcomes. The interventional radiologist must weigh the advantages and disadvantages of various animal models available when testing a new local-regional therapy. This review highlights the currently available animal models for testing local-regional therapies for HCC and details the importance of considering animal genetics, tumor biology, and molecular mechanisms when ultimately choosing an animal model. (C)RSNA, 2022
引用
收藏
页数：9
相关论文
共 50 条
  • [1] Hepatocellular carcinoma: local-regional treatment
    Fleig, WE
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2003, 128 : S102 - S103
  • [2] Local-Regional Treatment of Hepatocellular Carcinoma
    Lencioni, Riccardo
    Crocetti, Laura
    RADIOLOGY, 2012, 262 (01) : 43 - 58
  • [3] Local-Regional Treatment of Hepatocellular Carcinoma: A Primer for Radiologists
    Horvat, Natally
    De Oliveira, Ana I.
    De Oliveira, Brunna Clemente
    Araujo-Filho, Jose A. B.
    El Homsi, Maria
    Elsakka, Ahmed
    Bajwa, Raazi
    Martins, Guilherme L. P.
    Elsayes, Khaled M.
    Menezes, Marcos R.
    RADIOGRAPHICS, 2022, 42 (06) : 1670 - 1689
  • [4] Local and Regional Therapies for Hepatocellular Carcinoma
    Kloeckner, Roman
    Robert Galle, Peter
    Bruix, Jordi
    HEPATOLOGY, 2021, 73 : 137 - 149
  • [5] Intraarterial Therapies for the Management of Hepatocellular Carcinoma
    Garg, Tushar
    Shrigiriwar, Apurva
    Habibollahi, Peiman
    Cristescu, Mircea
    Liddell, Robert P.
    Chapiro, Julius
    Inglis, Peter
    Camacho, Juan C.
    Nezami, Nariman
    CANCERS, 2022, 14 (14)
  • [6] Local and Regional Therapies for Hepatocellular Carcinoma and Future Combinations
    Hatzidakis, Adam
    Mueller, Lukas
    Krokidis, Miltiadis
    Kloeckner, Roman
    CANCERS, 2022, 14 (10)
  • [7] Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review
    Jansen, MC
    van Hillegersberg, R
    Chamuleau, RAFM
    van Delden, OM
    Gouma, DJ
    van Gulik, TM
    EJSO, 2005, 31 (04): : 331 - 347
  • [8] Intraarterial Therapies of Hepatocellular Carcinoma: Clinical Evidence and Future Outlook
    Duran, R.
    Geschwind, J. -F.
    ONCOLOGIE, 2017, 19 (5-6) : 158 - 167
  • [9] Initial experience of combination nivolumab and local-regional treatment in patients with advanced hepatocellular carcinoma (HCC)
    Gu, Ping
    Park, James
    Zhong, Judy
    Guo, Songchuang
    Hickey, Ryan
    Aaltonen, Eric
    Horn, Jeremy
    Du, Kevin Lee
    Shanbhogue, Krishna
    Megibow, Alec
    Xu, Ruliang
    Kyritsis, Irene
    Cohen, Deirdre Jill
    Newman, Elliot
    Miller, George
    Welling, Theodore
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] The AFCRPLITY score for predicting the prognosis of immunotherapy combined with local-regional therapy in unresectable hepatocellular carcinoma
    Zuo, Mengxuan
    Wei, Ran
    Li, Da
    Li, Wang
    An, Chao
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
12345